CANY
BAK icon

Caxton Associates (New York)’s Braskem BAK Stock Holding History

Caxton Associates (New York)’s Portfolio BAK Stock Details BAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-135,000
Closed -$3.9M – 284
2018
Q3 		$3.9M Buy
135,000
+55,000
+69% +$1.56M 0.27% 85
2018
Q2 		$2.08M Buy
+80,000
New +$2.06M 0.11% 126
2018
Q1 		– Sell
-230,000
Closed -$6.04M – 325
2017
Q4 		$6.04M Sell
230,000
-37,600
-14% -$1.07M 0.3% 87
2017
Q3 		$7.16M Buy
+267,600
New +$6.57M 0.26% 99

Other funds holding BAK

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Contrarian Capital Management Greenwich, Connecticut $357M AUM 18.27% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return

Caxton Associates (New York)'s BAK Position: Q4 2018 in Review

Caxton Associates (New York) sold out of Braskem (BAK) in Q4 2018, closing a stake of 135,000 shares — an estimated $3.9M sold.

Caxton Associates (New York) first reported a position in BAK in Q3 2017 and held it in 4 quarters. The position peaked at $7.16M in Q3 2017. 85 funds tracked by Wall St. Rank hold BAK as of Q4 2018.

  • Caxton Associates (New York) reported no remaining Braskem position as of Q4 2018 after selling out during the quarter.
  • Caxton Associates (New York) sold 135,000 Braskem shares in Q4 2018, an estimated $3.9M.
  • Caxton Associates (New York) first reported a position in Braskem in Q3 2017 and held it in 4 quarters.
  • Caxton Associates (New York)'s Braskem position peaked at $7.16M in Q3 2017.
  • 85 funds tracked by Wall St. Rank held Braskem as of Q4 2018.

Based on Caxton Associates (New York)'s 13F filing for Q4 2018, filed 14 Feb 2019.